Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

628
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dehydration and Rehydration Behavior of Ultra-High-Fluence Extracorporeal Cross-Linked Corneal Allogenic Intrastromal Ring Segments (ECO-CAIRS).

Journal of cataract and refractive surgery·2026
Same author

Risk behaviors for infectious Keratitis among contact lens wearers in Switzerland: an analysis by contact lens type.

Journal of optometry·2026
Same author

Second-Generation ELZA-sub400 Protocol: Individualized High-Fluence Cross-Linking for Ultra-Thin Keratoconus Corneas.

American journal of ophthalmology·2026
Same author

Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics.

Progress in retinal and eye research·2026
Same author

Comment on "Impact of Simultaneous Topography-Guided PRK on Corneal Haze after Cross-Linking for Keratoconus: A Quantitative Densitometry Analysis".

Cornea·2026
Same author

Integration of Mechanical Testing, In Vivo Optical Coherence Elastography and Personalized Finite Element Modeling to Predict Geometrical Outcomes of Corneal Cross-Linking.

Annals of biomedical engineering·2026

Related Experiment Video

Updated: Aug 28, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.0K

Corneal Cross-Linking: Epi-On.

Farhad Hafezi1,2,3,4,5

  • 1ELZA Institute AG, Dietikon/Zurich, Switzerland.

Cornea
|September 15, 2022
PubMed
Summary
This summary is machine-generated.

Epithelium-on corneal cross-linking (CXL) offers a less painful alternative to traditional epithelium-off CXL for treating corneal ectasias. Advanced techniques now achieve comparable efficacy, potentially reducing postoperative complications.

More Related Videos

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

7.9K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.0K

Related Experiment Videos

Last Updated: Aug 28, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.0K
Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

7.9K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.0K

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Corneal Science

Background:

  • Corneal cross-linking (CXL) is essential for treating corneal ectasias.
  • Traditional epithelium-off (epi-off) CXL involves debridement, leading to pain and infection risk.
  • Epithelium-on (epi-on) CXL aims to mitigate these adverse effects.

Purpose of the Study:

  • To evaluate advanced methods for achieving effective epithelium-on corneal cross-linking.
  • To overcome challenges of riboflavin penetration and oxygen availability in epi-on CXL.
  • To compare the efficacy of novel epi-on CXL with standard epi-off CXL.

Main Methods:

  • Utilizing penetration enhancers for riboflavin delivery through the epithelium.
  • Optimizing ultraviolet (UV) irradiation profiles.
  • Employing atmospheric oxygen to enhance stromal saturation.
  • Investigating iontophoresis and supplemental oxygen delivery systems.

Main Results:

  • Epi-on CXL techniques using penetration enhancers and optimized UV profiles show promise.
  • The epithelium absorbs UV energy and impedes oxygen diffusion, requiring specific compensatory strategies.
  • Laboratory advancements demonstrate that optimized epi-on CXL can match the efficacy of epi-off CXL.

Conclusions:

  • Simple and effective epithelium-on CXL is nearing clinical application.
  • This approach has the potential to reduce pain and postoperative complications associated with CXL.
  • Further research and clinical trials are needed to validate these advanced epi-on CXL techniques.